My Quote Request
6505-01-228-5997
20 Products
NDC17478-0200-15
PHENYLEPHRINE HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505012285997
NSN
6505-01-228-5997
NDC17478-0200-15
PHENYLEPHRINE HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505012285997
NSN
6505-01-228-5997
MFG
AKORN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 PERCENTAGE, W/V PHENYLEPHRINE HYDROCHLORIDE OPHTHALMIC ACTIVE INGREDIENT
ADMINISTRATION: OPHTHALMIC
FEATURES PROVIDED: STERILE
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC SQUEEZE
Related Searches:
NDC00045-0508-40
ACETAMINOPHEN AND CODEINE PHOSPHATE ELIXIR,USP
NSN, MFG P/N
6505012277993
NSN
6505-01-227-7993
NDC00045-0508-40
ACETAMINOPHEN AND CODEINE PHOSPHATE ELIXIR,USP
NSN, MFG P/N
6505012277993
NSN
6505-01-227-7993
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 24.000 MILLIGRAMS ACETAMINOPHEN PER MILLILITER AND 2.400 MILLIGRAMS CODEINE PHOSPHATE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: PATIENT CUP
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
FORTAZ
CEFTAZIDIME FOR INJECTION,USP
NSN, MFG P/N
6505012280009
NSN
6505-01-228-0009
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME FOR INJECTION USP 2GM VIAL 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SECONDARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: EACH VIAL CONTAINS CEFTAZIDIME PENTAHYDRATE EQUIVALENT TO 2 GRAMS OF CEFTATAZIDIME AND 118 MILLIGRAMS SODIUM CARBONATE PER GRAM OF CEFTAZIDIME
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
K5084-11
CEFTAZIDIME FOR INJECTION,USP
NSN, MFG P/N
6505012280009
NSN
6505-01-228-0009
K5084-11
CEFTAZIDIME FOR INJECTION,USP
NSN, MFG P/N
6505012280009
NSN
6505-01-228-0009
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME FOR INJECTION USP 2GM VIAL 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SECONDARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: EACH VIAL CONTAINS CEFTAZIDIME PENTAHYDRATE EQUIVALENT TO 2 GRAMS OF CEFTATAZIDIME AND 118 MILLIGRAMS SODIUM CARBONATE PER GRAM OF CEFTAZIDIME
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00002-7234-10
CEFTAZIDIME FOR INJECTION,USP
NSN, MFG P/N
6505012280009
NSN
6505-01-228-0009
NDC00002-7234-10
CEFTAZIDIME FOR INJECTION,USP
NSN, MFG P/N
6505012280009
NSN
6505-01-228-0009
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME FOR INJECTION USP 2GM VIAL 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SECONDARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: EACH VIAL CONTAINS CEFTAZIDIME PENTAHYDRATE EQUIVALENT TO 2 GRAMS OF CEFTATAZIDIME AND 118 MILLIGRAMS SODIUM CARBONATE PER GRAM OF CEFTAZIDIME
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00007-5084-11
CEFTAZIDIME FOR INJECTION,USP
NSN, MFG P/N
6505012280009
NSN
6505-01-228-0009
NDC00007-5084-11
CEFTAZIDIME FOR INJECTION,USP
NSN, MFG P/N
6505012280009
NSN
6505-01-228-0009
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME FOR INJECTION USP 2GM VIAL 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SECONDARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: EACH VIAL CONTAINS CEFTAZIDIME PENTAHYDRATE EQUIVALENT TO 2 GRAMS OF CEFTATAZIDIME AND 118 MILLIGRAMS SODIUM CARBONATE PER GRAM OF CEFTAZIDIME
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00173-0379-34
CEFTAZIDIME FOR INJECTION,USP
NSN, MFG P/N
6505012280009
NSN
6505-01-228-0009
NDC00173-0379-34
CEFTAZIDIME FOR INJECTION,USP
NSN, MFG P/N
6505012280009
NSN
6505-01-228-0009
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME FOR INJECTION USP 2GM VIAL 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SECONDARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: EACH VIAL CONTAINS CEFTAZIDIME PENTAHYDRATE EQUIVALENT TO 2 GRAMS OF CEFTATAZIDIME AND 118 MILLIGRAMS SODIUM CARBONATE PER GRAM OF CEFTAZIDIME
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
TAZICEF
CEFTAZIDIME FOR INJECTION,USP
NSN, MFG P/N
6505012280009
NSN
6505-01-228-0009
TAZICEF
CEFTAZIDIME FOR INJECTION,USP
NSN, MFG P/N
6505012280009
NSN
6505-01-228-0009
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME FOR INJECTION USP 2GM VIAL 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SECONDARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: EACH VIAL CONTAINS CEFTAZIDIME PENTAHYDRATE EQUIVALENT TO 2 GRAMS OF CEFTATAZIDIME AND 118 MILLIGRAMS SODIUM CARBONATE PER GRAM OF CEFTAZIDIME
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
TAZIDIME
CEFTAZIDIME FOR INJECTION,USP
NSN, MFG P/N
6505012280009
NSN
6505-01-228-0009
TAZIDIME
CEFTAZIDIME FOR INJECTION,USP
NSN, MFG P/N
6505012280009
NSN
6505-01-228-0009
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME FOR INJECTION USP 2GM VIAL 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SECONDARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: EACH VIAL CONTAINS CEFTAZIDIME PENTAHYDRATE EQUIVALENT TO 2 GRAMS OF CEFTATAZIDIME AND 118 MILLIGRAMS SODIUM CARBONATE PER GRAM OF CEFTAZIDIME
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
7974-08
GLYCINE IRRIGATION,USP
NSN, MFG P/N
6505012280810
NSN
6505-01-228-0810
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.500 PERCENTAGE, W/V GLYCINE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 3000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG
TOTAL PRIMARY CONTAINER QUANTITY: 4
Related Searches:
NDC00074-7974-08
GLYCINE IRRIGATION,USP
NSN, MFG P/N
6505012280810
NSN
6505-01-228-0810
NDC00074-7974-08
GLYCINE IRRIGATION,USP
NSN, MFG P/N
6505012280810
NSN
6505-01-228-0810
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.500 PERCENTAGE, W/V GLYCINE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 3000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG
TOTAL PRIMARY CONTAINER QUANTITY: 4
Related Searches:
03060
PSYLLIUM HYDROPHILIC MUCILLOID
NSN, MFG P/N
6505012281281
NSN
6505-01-228-1281
MFG
RYDELLE LABORATORIES INC SUB OF JOHNSON S C AND SON INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.680 GRAMS PSYLLIUM HYDROPHILIC MUCILLOID PER GRAM
ADMINISTRATION: ORAL
FLAVOR: REGULAR
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 OUNCES
PRIMARY CONTAINER TYPE: CAN
SPECIAL FEATURES: UNFLAVORED; SUGAR-FREE
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
FIBERALL
PSYLLIUM HYDROPHILIC MUCILLOID
NSN, MFG P/N
6505012281281
NSN
6505-01-228-1281
FIBERALL
PSYLLIUM HYDROPHILIC MUCILLOID
NSN, MFG P/N
6505012281281
NSN
6505-01-228-1281
MFG
RYDELLE LABORATORIES INC SUB OF JOHNSON S C AND SON INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.680 GRAMS PSYLLIUM HYDROPHILIC MUCILLOID PER GRAM
ADMINISTRATION: ORAL
FLAVOR: REGULAR
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 OUNCES
PRIMARY CONTAINER TYPE: CAN
SPECIAL FEATURES: UNFLAVORED; SUGAR-FREE
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
NDC00536-3371-10
BENZTROPINE MESYLATE TABLETS,USP
NSN, MFG P/N
6505012281284
NSN
6505-01-228-1284
NDC00536-3371-10
BENZTROPINE MESYLATE TABLETS,USP
NSN, MFG P/N
6505012281284
NSN
6505-01-228-1284
MFG
CHELSEA LABORATORIES INC DIV OF RUGBY LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS BENZTROPINE MESYLATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:COMPRESSION
Related Searches:
ISORDIL TITRADOSE
ISOSORBIDE DINITRATE TABLETS,USP
NSN, MFG P/N
6505012281285
NSN
6505-01-228-1285
ISORDIL TITRADOSE
ISOSORBIDE DINITRATE TABLETS,USP
NSN, MFG P/N
6505012281285
NSN
6505-01-228-1285
MFG
IVES LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS ISOSORBIDE DINITRATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:COMPRESSION
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00082-4192-01
ISOSORBIDE DINITRATE TABLETS,USP
NSN, MFG P/N
6505012281285
NSN
6505-01-228-1285
NDC00082-4192-01
ISOSORBIDE DINITRATE TABLETS,USP
NSN, MFG P/N
6505012281285
NSN
6505-01-228-1285
MFG
IVES LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS ISOSORBIDE DINITRATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:COMPRESSION
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
111-20
OPHTHALMIC IRRIGATING SOLUTION
NSN, MFG P/N
6505012284362
NSN
6505-01-228-4362
111-20
OPHTHALMIC IRRIGATING SOLUTION
NSN, MFG P/N
6505012284362
NSN
6505-01-228-4362
MFG
DEY LP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.048 PERCENTAGE, W/V CALCIUM CHLORIDE PER MILLILITER AND 0.030 PERCENTAGE, W/V MAGNESIUM CHLORIDE PER MILLILITER AND 0.075 PERCENTAGE, W/V POTASSIUM CHLORIDE PER MILLILITER AND 0.390 PERCENTAGE, W/V SODIUM ACETATE PER MILLILITER AND 0.490 PERCENTAGE, W/V
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 9 VIAL
PRIMARY CONTAINER TYPE: VIAL
SECONDARY CONTAINER TYPE: BOX
TOTAL PRIMARY CONTAINER QUANTITY: 36
TOTAL SECONDARY CONTAINER QUANTITY: 4
~1: SODIUM CHLORIDE PER MILLILITER AND 0.170 PERCENTAGE, W/V SODIUM CITRATE PER MILLILITER
Related Searches:
I-SOL
OPHTHALMIC IRRIGATING SOLUTION
NSN, MFG P/N
6505012284362
NSN
6505-01-228-4362
MFG
DEY LP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.048 PERCENTAGE, W/V CALCIUM CHLORIDE PER MILLILITER AND 0.030 PERCENTAGE, W/V MAGNESIUM CHLORIDE PER MILLILITER AND 0.075 PERCENTAGE, W/V POTASSIUM CHLORIDE PER MILLILITER AND 0.390 PERCENTAGE, W/V SODIUM ACETATE PER MILLILITER AND 0.490 PERCENTAGE, W/V
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 9 VIAL
PRIMARY CONTAINER TYPE: VIAL
SECONDARY CONTAINER TYPE: BOX
TOTAL PRIMARY CONTAINER QUANTITY: 36
TOTAL SECONDARY CONTAINER QUANTITY: 4
~1: SODIUM CHLORIDE PER MILLILITER AND 0.170 PERCENTAGE, W/V SODIUM CITRATE PER MILLILITER
Related Searches:
NDC49502-0111-20
OPHTHALMIC IRRIGATING SOLUTION
NSN, MFG P/N
6505012284362
NSN
6505-01-228-4362
NDC49502-0111-20
OPHTHALMIC IRRIGATING SOLUTION
NSN, MFG P/N
6505012284362
NSN
6505-01-228-4362
MFG
DEY LP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.048 PERCENTAGE, W/V CALCIUM CHLORIDE PER MILLILITER AND 0.030 PERCENTAGE, W/V MAGNESIUM CHLORIDE PER MILLILITER AND 0.075 PERCENTAGE, W/V POTASSIUM CHLORIDE PER MILLILITER AND 0.390 PERCENTAGE, W/V SODIUM ACETATE PER MILLILITER AND 0.490 PERCENTAGE, W/V
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 9 VIAL
PRIMARY CONTAINER TYPE: VIAL
SECONDARY CONTAINER TYPE: BOX
TOTAL PRIMARY CONTAINER QUANTITY: 36
TOTAL SECONDARY CONTAINER QUANTITY: 4
~1: SODIUM CHLORIDE PER MILLILITER AND 0.170 PERCENTAGE, W/V SODIUM CITRATE PER MILLILITER
Related Searches:
AK-DILATE
PHENYLEPHRINE HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505012285997
NSN
6505-01-228-5997
AK-DILATE
PHENYLEPHRINE HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505012285997
NSN
6505-01-228-5997
MFG
AKORN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 PERCENTAGE, W/V PHENYLEPHRINE HYDROCHLORIDE OPHTHALMIC ACTIVE INGREDIENT
ADMINISTRATION: OPHTHALMIC
FEATURES PROVIDED: STERILE
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC SQUEEZE